Paul Tudor Jones (Trades, Portfolio) is the president and founder of Tudor Investment Corporation, the first of the Tudor Group companies, which is a group of affiliated entities engaged in the management of client and proprietary assets. The Tudor Group manages assets across fixed income, currency, equity and commodity asset classes and related derivative instruments in the global markets for an international clientele.
He manages a portfolio comprised of 1,464 stocks with a total value of $3,419 million. During the last quarter, he bought more than 350 new stocks, and the following are the largest buys.
He bought 319,000 shares of Pall Corporation (PLL) with an impact of 1.16% on his portfolio. The company supplies filtration, separation and purification technologies. Its products are used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases. It serves its customers through two businesses: Life Sciences and Industrial.
Pall has a profitability and growth rating of 8 out of 10 with strong returns (ROE 22.89%, ROA 10.41%) that are outperforming 89% of the Global Diversified Industrials industry. Financial strength has a rating of 6 out of 10 with a cash to debt of 0.93 that is slightly below the industry median of 0.97.
The price of the stock has risen by 208% during the last five years, by 25% year to date and by 51% during the last 12 months. It is currently 0.19% below its 52-week high and 59.21% above its 52-week low.
Recently, its Ilfracombe manufacturing facility won the gold medal in the 2015 edition of The Royal Society for the Prevention of Accidents (RoSPA) Occupational Health and Safety Awards.Â
Meridian Funds (Trades, Portfolio) is the main shareholder with 0.62% of outstanding shares, followed by Mario Gabelli (Trades, Portfolio) with 0.39% and Paul Tudor Jones (Trades, Portfolio) with 0.30%.
Tudor Jones bought 736,643 shares of Broadcom Corp. (BRCM) with an impact of 1.11% on his portfolio. The company is provider of semiconductors for wired and wireless communications. It provides a portfolio of SoCs that seamlessly deliver voice, video, data and multimedia connectivity in the home, office and mobile environments. Its business segments include Broadband and Connectivity, and Infrastructure and Networking.
Broadcom has a profitability and growth rating of 7 out of 10 with strong returns such as ROE of 12.05% and ROA of 8.78% that are outperforming 73% of the Global Semiconductors industry. Financial strength has a rating of 4 out of 10 with a strong cash to debt ratio of 2.00 that is slightly above the industry median of 1.75.
The price of the stock has risen by 59% during the last five years, by 25% year to date and by 29% during the last 12 months. It is currently 7.31% below its 52-week high and 55.01% above its 52-week low.
Driven by growth in the high-end smartphone, broadband access, and networking markets, Broadcom delivered revenue that was up sequentially and year over year during the second quarter.
John Paulson (Trades, Portfolio) is the main shareholder of the company with 0.69% of outstanding shares, followed by PRIMECAP Management (Trades, Portfolio) with 0.61% and Pioneer Investments (Trades, Portfolio) with 0.56%.
He bought 353,628 shares of Omnicare Inc. (OCR) with an impact of 0.97% on his portfolio. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The company operates two primary businesses, Long-Term Care Group and Specialty Care Group.
Omnicare has a profitability and growth rating of 7 out of 10 with weak returns. ROE is 6.58% and ROA is 2.71%, which is underperforming 58% of the Global Medical Care industry. Financial strength has a rating of 6 out of 10 with a negative cash to debt of 0.15 that is below the industry median of 0.33.
The price of the stock has risen by 346% during the last five years, by 34% year to date and by 55% during the last 12 months.
During the last quarter, Omnicare and CVS Health Corporation (CVS) entered into a definitive agreement under which a subsidiary of CVS will acquire Omnicare for $98 per share in cash, for a total enterprise value of approximately $12.9 billion. Omnicare delivered strong results in which net sales increased by 7.6% and adjusted operating income from continuing operations increased by 11.4% .
James Barrow (Trades, Portfolio) is the main shareholder of the company with 3.05% of outstanding shares, followed by Joel Greenblatt (Trades, Portfolio) with 0.89% and Jeremy Grantham (Trades, Portfolio) with 0.56%.
He bought 180,700 shares of Sigma-Aldrich Corp. (SIAL) with an impact of 0.74% on his portfolio. The company is a life science and a technology company that helps in enhancing human health and safety. The company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs, as well as in industrial and commercial markets. The company operates in three units: Research, Applied and SAFC Commercial.
Sigma-Aldrich has a profitability and growth rating of 8 out of 10 with strong returns (ROE 15.42%, ROA 11.82%) that are outperforming 77% of the Global Specialty Chemicals industry. The financial situation is strong as well with a rating of 8 out of 10 with a positive cash to debt of 3.50 that is far above the industry median of 0.60.
The price of the stock has risen by 134% during the last five years, by 2% year to date and by 35% during the last 12 months. It is currently 0.23% below its 52-week high and 36.62% above its 52-week low.
During the last quarter, gross profit was 51%, the same level from the year-ago quarter. Recent acquisitions increased sales by 1% and total sales grew organically by 8%, and changes in foreign currency exchange rates decreased sales by 9%.
Donald Yacktman is the main shareholder of the company with 1.18% of outstanding shares, followed by Yacktman Fund (Trades, Portfolio) with 0.67% and Jim Simons (Trades, Portfolio) with 0.57%.
Tudor Jones bought 666,245 shares of Associated Estates Realty Corp. (AEC) with an impact of 0.56% on his portfolio. The company is engaged in multifamily ownership, operation, acquisition, development, construction, disposition and property management activities. It owns a taxable REIT subsidiary that performs general contracting and construction services for its own account in connection with the development of multifamily properties that it owns and operates.
Associated Estates has a profitability and growth rating of 5 out of 10 with good returns, ROE is 10.95% and ROA is 4.78% that are outperforming 64% of the Global Diversified Industrials industry. Financial situation has a rating of 4 out of 10 with a cash to debt of 0.01 that is below the industry median of 0.05.
The price of the stock has risen by 94% during the last five years, by 22% year to date and by 62% during the last 12 months.
Recently, the company reported the successful completion of the acquisition of Brookfield Asset Management Inc. (BAM). BAM acquired all outstanding shares of common stock of Associated Estates for $28.75 per share in cash.
Paul Tudor Jones (Trades, Portfolio) is the main shareholder of the company with 1.15% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 0.40% and Mario Gabelli (Trades, Portfolio) with 0.02%.
